JIM 2021: Live Cases from Rotterdam
The conference sessions aim to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care.
To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from the Thoraxcenter, Erasmus, Rotterdam, interspersed with a panel debate session.
This year, registration for JIM 2021 will be free of charge.
Register now in order to access the online live case meeting.
Nicolas M Van Mieghem
Carlos Di Mario
Jeffrey W Moses
Single access TVI with complex peripheral anatomy using ACURATE neo2 with Prof Nicolas Van Mieghem
Retrograde CTO of the RCA with Dr Roberto Diletti and Dr Jeroen Wilschut
The panel discuss JIM 2021 over a 90-minute session
- Surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease
Nicolas M Van Mieghem
Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010.
He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals.
Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently Medical Director of the department of Interventional cardiology at the Thoraxcenter.
Director, Cardiac Cath Lab and Interventional Cardiology Unit, EMO GVM Centro Cuore, Columbus and San Raffaele Hospital, Milan, Italy, Visiting Professor of Medicine, Columbia Medical Center.
Dr Colombo pioneered the concept of adequate stent deployment during coronary interventions, and he defined the role of intravascular ultrasound in this setting. Dr Colombo is very active in multiple medical societies, including the American College of Cardiology, the American Heart Association, the American College of Physicians, the American College of Chest Physicians and the American Medical Association. Dr Colombo obtained his MD from the University of Milan School of Medicine in 1975.
Dr Eberhard Grube is Professor of Medicine, Chief of the Department of Cardiology and Angiology at University Hospital Bonn, Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
Dr Latib is Associate Professor at Department of Cardiology, Montefiore Medical Center, New York, NY, US.
He is also senior lecturer at Dipartimento Cardio-Toraco-Vascolare, Ospedale di San Raffaele Istituto di Ricovero e Cura a Carattere Scientifico.
Azeem does research in Cardiology and Medicine. Their current project is 'Bioresorbable coronay scaffolds and Vascular reparative therapy.'
2008:Masters in interventional cardiology
2005:Certificate in cardiology, College of physicians of South Africa
2002: Fellow of the College of College of physicians of South Africa (MM Suzman Medal)
1995: Bachelor of medicine and surgery
Dr Ghada Mikhail is a consultant interventional cardiologist at Imperial College Healthcare NHS Trust. She qualified from the Royal Free Hospital School of Medicine, and was awarded an MD from the University of London. She trained at the Royal Brompton and Harefield NHS Trust. She has gained international experience by spending a year in Italy, in a world renowned centre, on an interventional fellowship. Dr Mikhail has set up the valvular heart disease programme at Imperial College Healthcare NHS Trust for the treatment of patients with valvular heart disease using percutaneous techniques and performs the transcatheter aortic valve implantation (TAVI) procedure. She is the research lead for the programme and is the founder and director of the annual Imperial valve and cardiovascular course (IVCC). She is actively involved in the area of cardiovascular disease in women and has founded the Her at Heart scientific initiative in the UK, the aims of which are to address the issues of under-diagnosis, under-treatment and under-representation of women in research trials. She has chaired symposia and presented at national and international meetings and is widely published on the same subject. She is a member of the British Cardiovascular Society working group for women's heart health and was involved in the European Society of Cardiology Women at Heart policy conference. She is on the Board of the WIN (Women in Innovations) initiative of the Society of Cardiovascular Angiography and Interventions and also a board member of the European EAPCI women group. Dr Mikhail has given TV, press and radio interviews on the under-recognition of cardiovascular disease in women.
General and interventional cardiology, coronary angiography and angioplasty, valvular heart disease - transcatheter aortic valve implantation (TAVI), cardiovascular disease in women, permanent pacemaker implantation
Research & publications
Coronary angioplasty, transcatheter aortic valve implantation (TAVI), cardiovascular disease in women
Carlos Di Mario
Prof Carlo Di Mario was born in Modena, Italy and graduated in medicine, specialising in cardiology, from the University of Padua. He trained in interventional cardiology and worked at the Erasmus University of Rotterdam, the Netherlands, where he completed his PhD. He became professor of cardiology at the University of Florence and director of structural interventional cardiology at the Careggi University Hospital, Florence, Italy.
He has previously served as research and clinical director for interventional cardiology at the University Vita-Salute of the San Raffaele Hospital in Milan and consultant cardiologist at the Royal Brompton and Harefield NHS Foundation Trust. Between January 2003 and November 2016, he was professor of clinical cardiology, NHLI, Imperial College of Sciences, Medicine and Technology, and consultant cardiologist of the Royal Brompton and Harefield Foundation Trust, London. He was appointed in 2010 as senior investigator of the National Institute of Health Research. He is a certified implanter for the Medtronic Evolut R, Edwards Sapien 3 transcatheter aortic valves. He has eight years of experience with MitraClips and started implants of CardioBand in 2017.
Prof Di Mario has served as secretary of the Working Group on Interventional Cardiology of the European Society of Cardiology (ESC) and was president of the European Association of Percutaneous Cardiovascular Interventions between 2009 and 2011. Between 2012 and 2014, he served as councillor of the ESC. He has been a member of the writing committee of many guidelines task forces of the ESC and is first/last author or co-author of many expert consensus documents.
Jeffrey W Moses
Dr Moses currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. Dr. Moses is an Associate Director of the Transcatheter Cardiovascular Therapeutics (TCT) conference, the world’s largest interventional cardiology conference.
He serves on the Board of the Cardiovascular Research Foundation in New York City; and he has made important contributions in the areas of clinical research and educational activities in interventional vascular therapy. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Honors & Awards
Research Fellowship Award, Southern Pennsylvania Heart Assoc. 1978-1980
Member, PTCA Subcommittee NHLBI-Study of Thrombolysis in
Acute Myocardial Infarction (TIMI) 1986-1987
Consultant: FDA Committee on Biologics 1986
Chairman: New York Angioplasty Society 1987-1988
Lectureship, Sendai Medical College, Tohoku Medical Society,
Sendai, Japan 1990
Lectureship, The Vivian & Norman Weiden Lecture: Innovative
Approaches to Coronary Artery Disease 1996
New York Cardiological Society, NYC
Listed in Best Doctors of the Year, New York Magazine 2004-2016
America’s Top Doctors –Castle Connolly 2005-2016
Lifetime Achievement Award, Cardiovascular Research Foundation 2006
C3 Lifetime Career Achievement Award-C3 Hall of Fame 2010